Extensive Cancer Cases is Surging the Global DNA Sequencing Market at 17.46% of CAGR
According to a new market research report published by Inkwood Research, the Global DNA Sequencing Market is escalating at a compound annual growth rate of 17.46% between 2019 and 2027.
"Browse 43 market Data Tables and 51 Figures spread over 230 Pages, along with an in-depth TOC on Global DNA Sequencing Market Forecast 2019-2027".
REQUEST FREE SAMPLE LINK- https://www.inkwoodresearch.com/reports/dna-sequencing-market/#request-free-sample
Prevalence of Cancer Cases - Primary Growth Driver
Increasing incidence of cancer cases is a major driver boosting the global DNA Sequencing market. The cancer studies of the genomic period are witnessing tremendous growth, pushed by the introduction of next-generation sequencing techniques with advantages, such as sensitivity and sharp resolution. The conventional techniques of discovering the genomic foundations of diverse cancers involved targeted examination of particular variants and genes in a low-throughput fashion. The majority of cancers are genetically composite and are better distinct by the creation of signaling pathways rather than a definite set of mutations. The success of the human genome project encouraged similar projects looking at the genome in several cancers. That success, along with the augmented reliability and affordability of sequencing, has led to the addition of genome science into medical practice, which in turn is driving the global DNA sequencing market.
To know more about this report, request a free sample copy.
Biomarkers - Most Popular Application in the DNA Sequencing Market
Biomarkers are the essential elements that assist in diagnosing the presence of disease. The Improvisation of treatment and inhibition of chronic conditions such as diabetes, cancer and cardiovascular diseases is potentially probable through the intervention of biomarkers. The clinical relevance of molecular biomarkers and translational research in the treatment of diseases has been relatively uncertain due to genetic variability among patients with the same condition. Nevertheless, DNA sequencing is capable of recognizing a broad spectrum of genetic differences and enhance the introduction of important biomarkers in medicine and disease diagnosis. Thus, it can be stated that DNA sequencing has revolutionized the discovery and identification of different biomarkers.
North America - Dominant Region in the Global Market
The global market for DNA sequencing is dominated by the North American region in terms of revenue in the year 2019, and is expected to continue its lead over the forecasting period. The attributes supplementing the regional market are various cases of chronic disorders and a rise in the geriatric population. Also, the prevailing instances of cancer types, including lung, breast, prostate, bronchus, rectum, colon, melanoma of the skin, leukemia, and others, are propelling the demand for DNA sequencing in the region.
The global DNA sequencing market is marked by high competition led by dominant players, such as Illumina, Thermo Fisher Scientific, and Roche Diagnostics. These companies deploy strategies such as the launch of novel platforms that are faster, smaller in size, and less expensive to improve their market presence. The other prominent vendors in the market are Agilent Technologies, Adaptive Biotechnologies, and WaferGen Bio-Systems. These companies are also looking for efficient products for fast and accurate DNA sequencing.
About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
+1 857-302-4704
Related Report:
GLOBAL DNA VACCINE MARKET FORECAST 2018-2026
GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET FORECAST 2018-2026
GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027
GLOBAL METAGENOMICS MARKET FORECAST 2019-2027